Current knowledge in genetics, molecular diagnostic tools, and treatments for mantle cell lymphomas Review


Authors: Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Ho, C.
Review Title: Current knowledge in genetics, molecular diagnostic tools, and treatments for mantle cell lymphomas
Abstract: Mantle Cell lymphoma (MCL) is a mature B-cell lymphoma with a well-known hallmark genetic alteration in most cases, t (11,14)(q13q32)/CCND1-IGH. However, our understanding of the genetic and epigenetic alterations in MCL has evolved over the years, and it is now known that translocations involving CCND2, or cryptic insertion of enhancer elements of IGK or IGL gene, can also lead to MCL. On a molecular level, MCL can be broadly classified into two subtypes, conventional MCL (cMCL) and non-nodal MCL (nnMCL), each with different postulated tumor cell origin, clinical presentation and behavior, mutational pattern as well as genomic complexity. This article reviews both the common and rare alterations in MCL on a gene mutational, chromosomal arm, and epigenetic level, in the context of their contribution to the lymphomagenesis and disease evolution in MCL. This article also summarizes the important prognostic factors, molecular diagnostic tools, and treatment options based on the most recent MCL literature. Copyright © 2021 Sethi, Epstein-Peterson, Kumar and Ho.
Keywords: mantle cell lymphoma; targeted therapy; immunochemotherapy; genetic; epigenetic; molecular diagnostics
Journal Title: Frontiers in Oncology
Volume: 11
ISSN: 2234-943X
Publisher: Frontiers Media S.A.  
Date Published: 2021-11-01
Start Page: 739441
Language: English
DOI: 10.3389/fonc.2021.739441
PROVIDER: scopus
PMCID: PMC8649949
PUBMED: 34888236
DOI/URL:
Notes: Review -- Export Date: 3 January 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anita Kumar
    195 Kumar
  2. Caleb   Ho
    73 Ho
  3. Shenon Sethi
    16 Sethi